American Vanguard (AVD) Upgraded by Zacks Investment Research to “Hold”

Zacks Investment Research upgraded shares of American Vanguard (NYSE:AVD) from a sell rating to a hold rating in a report released on Tuesday.

According to Zacks, “American Vanguard Corporation is a diversified specialty and agricultural products company focusing on crop protection, turf and ornamental markets, and public health applications. The Company has continued its successful strategy of acquiring or licensing both new and well-established product lines that serve numerous high valued market niches. New product development and international expansion also provide an additional stimulus for growth. Through skilful marketing, diligent product registration, quality manufacturing, American Vanguard has positioned itself to capitalize on developing trends in modern agriculture. American Vanguard continues to meet the needs of a world demanding ever-increasing quantities of agricultural products for human food, animal feed, natural fibers and alternative fuels. “

Separately, ValuEngine cut American Vanguard from a buy rating to a hold rating in a research report on Wednesday, August 8th.

NYSE:AVD opened at $16.92 on Tuesday. American Vanguard has a 52 week low of $16.72 and a 52 week high of $24.00. The company has a market capitalization of $545.84 million, a P/E ratio of 30.16 and a beta of 1.05. The company has a debt-to-equity ratio of 0.23, a quick ratio of 0.89 and a current ratio of 2.05.

American Vanguard (NYSE:AVD) last released its quarterly earnings data on Monday, August 6th. The basic materials company reported $0.19 EPS for the quarter, topping analysts’ consensus estimates of $0.17 by $0.02. American Vanguard had a return on equity of 6.29% and a net margin of 5.45%. The firm had revenue of $107.04 million for the quarter, compared to the consensus estimate of $111.90 million. During the same quarter in the prior year, the company posted $0.15 earnings per share. The firm’s revenue was up 37.4% on a year-over-year basis. On average, sell-side analysts anticipate that American Vanguard will post 0.79 EPS for the current year.

The business also recently announced a quarterly dividend, which will be paid on Wednesday, October 17th. Shareholders of record on Wednesday, October 3rd will be given a dividend of $0.02 per share. The ex-dividend date of this dividend is Tuesday, October 2nd. This represents a $0.08 dividend on an annualized basis and a yield of 0.47%. American Vanguard’s payout ratio is currently 14.04%.

In other American Vanguard news, CFO David` T. Johnson sold 9,940 shares of the company’s stock in a transaction that occurred on Monday, July 23rd. The stock was sold at an average price of $20.91, for a total transaction of $207,845.40. Following the completion of the sale, the chief financial officer now owns 36,095 shares of the company’s stock, valued at $754,746.45. The sale was disclosed in a document filed with the Securities & Exchange Commission, which can be accessed through the SEC website. 5.20% of the stock is owned by corporate insiders.

Institutional investors have recently made changes to their positions in the business. Piedmont Investment Advisors LLC bought a new stake in American Vanguard during the second quarter worth approximately $141,000. SG Americas Securities LLC bought a new stake in shares of American Vanguard in the second quarter valued at approximately $219,000. OppenheimerFunds Inc. bought a new stake in shares of American Vanguard in the second quarter valued at approximately $233,000. Dynamic Technology Lab Private Ltd bought a new stake in shares of American Vanguard in the first quarter valued at approximately $355,000. Finally, Barclays PLC boosted its position in shares of American Vanguard by 344.7% in the first quarter. Barclays PLC now owns 22,075 shares of the basic materials company’s stock valued at $446,000 after acquiring an additional 17,111 shares during the period. 74.64% of the stock is owned by hedge funds and other institutional investors.

American Vanguard Company Profile

American Vanguard Corporation, through its subsidiaries, develops, manufactures, and markets specialty chemicals for agricultural, commercial, and consumer uses in the United States and internationally. The company manufactures and formulates chemicals, including insecticides, fungicides, herbicides, molluscicides, growth regulators, and soil fumigants in liquid, powder, and granular forms for crops, turf and ornamental plants, and human and animal health protection.

Featured Story: Day Trading

Get a free copy of the Zacks research report on American Vanguard (AVD)

For more information about research offerings from Zacks Investment Research, visit

Receive News & Ratings for American Vanguard Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for American Vanguard and related companies with's FREE daily email newsletter.

Leave a Reply